Schizophrenia News and Research

Latest Schizophrenia News and Research

Antipsychotic polypharmacy may be beneficial for schizophrenia patients

Combining certain types of two antipsychotic agents in the maintenance treatment of schizophrenia is associated with a lower risk of relapse than using monotherapy. T

20 Feb 2019

UQ research may explain why vitamin D is essential for brain health

University of Queensland research may explain why vitamin D is vital for brain health, and how deficiency leads to disorders including depression and schizophrenia.

20 Feb 2019

Scientists probe into the mind of worms to unravel how memories form

Try as you might, some events cannot be remembered. Known in psychology as memory blocking, the phenomenon has remained elusive since first described more than half a century ago.

20 Feb 2019

Novel preclinical model mimics persistent interneuron loss seen in preterm infants

Research-clinicians at Children's National Health System have created a novel preclinical model that mimics the persistent interneuron loss seen in preterm human infants, identifying interneuron subtypes that could become future therapeutic targets to prevent or lessen neurodevelopmental risks, the team reports Jan. 31, 2019, in eNeuro.

20 Feb 2019

Study finds neuromelanin-sensitive MRI as potential biomarker for psychosis

Researchers have shown that a type of magnetic resonance imaging -- called neuromelanin-sensitive MRI is a potential biomarker for psychosis.

18 Feb 2019

Heavy smoking could lead to vision loss, study finds

Smoking more than 20 cigarettes a day can damage your vision, a study co-authored by a Rutgers researcher finds.

18 Feb 2019

UVA scientists find potential explanation for mysterious cell death in Alzheimer’s, Parkinson’s

Scientists at the University of Virginia School of Medicine have identified a potential explanation for the mysterious death of specific brain cells seen in Alzheimer’s, Parkinson’s and other neurodegenerative diseases.

15 Feb 2019

Researchers use optogenetic tool to control, visualize receptor signals in neural cells

Using a novel optogenetic tool, researchers have successfully controlled, reproduced and visualized serotonin receptor signals in neural cells. To this end, they modified a photosensitive membrane receptor in the eye, namely melanopsin.

15 Feb 2019

Study shows how neuroactive steroids inhibit activity of pro-inflammatory proteins

For the first time, scientists discovered how neuroactive steroids naturally found in the brain and bloodstream inhibit the activity of a specific kind of protein called Toll-like receptors, which have been known to play a role in inflammation in many organs, including the brain.

14 Feb 2019

New study provides insights into developmental organization of the brain

What makes us human, and where does this mysterious property of "humanness" come from? Humans are genetically similar to chimpanzees and bonobos, yet there exist obvious behavioral and cognitive differences.

13 Feb 2019

Machine learning algorithm could accelerate the search for new drugs

Researchers have designed a machine learning algorithm for drug discovery which has been shown to be twice as efficient as the industry standard, which could accelerate the process of developing new treatments for disease.

12 Feb 2019

New research opens the way for tailored cancer drugs

New research on how cancer mutations influence a certain type of receptor on the cell membrane opens the way for the development of tailored drugs for certain cancers, such as rectal cancer and lung cancer.

11 Feb 2019

Study finds low relapse risk in young patients with Hodgkin lymphoma

The treatment of Hodgkin lymphoma is now so effective that young patients who do not have a relapse within two years of therapy have a life expectancy similar to that of their healthy peers.

8 Feb 2019

Patients with psychosis have accelerated aging of cognitive networks, study finds

Patients with psychosis have accelerated aging of two brain networks important for general cognition—the frontoparietal network (FPN) and cingulo-opercular network (CON)—according to a new study in Biological Psychiatry.

7 Feb 2019

New acute porphyria treatment shows promising results in clinical study

Acute porphyria is a group of uncommon diseases that can cause severe, potentially life-threatening attacks of abdominal pain, nausea, vomiting and paralysis. Liver transplantation is currently the only effective treatment available for the most seriously afflicted patients.

7 Feb 2019

Large genetic analysis of impulsiveness reveals links with psychiatric disorders

Impulsiveness and substance use share a genetic basis, according to genome-wide association studies published in JNeurosci by academic and industry researchers.

From Society for Neuroscience 5 Feb 2019

Researchers identify treatable mechanism in patients with schizophrenia

For reasons that are unclear, schizophrenia patients have fewer connections between the neurons in the brain. Researchers at Karolinska Institutet, Sweden, and Massachusetts General Hospital, USA, have now succeeded in creating human cell models that show that there is an excessive degradation of connections in the brain of these patients, and they have been able to link this to a genetic risk variant for the disease.

4 Feb 2019

Newron announces successful completion of patient enrollment in STARS study

Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced the successful completion of patient enrollment in its STARS clinical study.

1 Feb 2019

New understanding could help improve prediction and prevention of depression

In a new study, researchers from the Danish iPSYCH project demonstrate that people with the highest genetic propensity are over two and a half times as likely to be treated in a psychiatric hospital for depression compared to people with the lowest propensity.

31 Jan 2019

New link found between psychiatric disorders and events during the prenatal stage

Particular genetic variants in the human genome that are important for the development of the brain early in the life of the fetus are frequently found in psychiatric disorders. This is shown by a study carried out by iPSYCH.

31 Jan 2019